Strategies implemented for accurate dispensing of an investigational new drug in a multi-site HIV prevention clinical trial
Safe practices for dispensing investigational product (IP) during clinical trials are not standardized and information in this regard is often limited. ASPIRE was a Phase 3 safety and effectiveness trial of a vaginal matrix ring containing 25 mg of dapivirine for the prevention of HIV-1 in women. Th...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Elsevier
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/f1a0194d2b9e41018ec43050784e0567 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|